Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
The Journal of Infectious Diseases
|
September 28, 2001
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy
C F Perno, A Cozzi-Lepri, C Balotta, et al.
The Journal of Antimicrobial Chemotherapy
|
December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen
D Armenia, D Di Carlo, A Calcagno, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2015
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia
D Armenia, L Fabeni, C Alteri, et al.
The Journal of Antimicrobial Chemotherapy
|
January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the years
D Armenia, D Di Carlo, P Flandre, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2017
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14
L Fabeni, C Alteri, D Di Carlo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels
V C Di Maio, V Cento, D Di Paolo, et al.
Infection
|
October 23, 2013
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group
V Svicher, C Alteri, M Montano, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
The Journal of Infectious Diseases
|
September 28, 2001
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy
C F Perno, A Cozzi-Lepri, C Balotta, et al.
The Journal of Antimicrobial Chemotherapy
|
December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen
D Armenia, D Di Carlo, A Calcagno, et al.
The Journal of Antimicrobial Chemotherapy
|
February 26, 2015
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia
D Armenia, L Fabeni, C Alteri, et al.
The Journal of Antimicrobial Chemotherapy
|
January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the years
D Armenia, D Di Carlo, P Flandre, et al.
The Journal of Antimicrobial Chemotherapy
|
November 2, 2017
Dynamics and phylogenetic relationships of HIV-1 transmitted drug resistance according to subtype in Italy over the years 2000-14
L Fabeni, C Alteri, D Di Carlo, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2015
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels
V C Di Maio, V Cento, D Di Paolo, et al.
Infection
|
October 23, 2013
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group
V Svicher, C Alteri, M Montano, et al.
Page
of 12